FOXP3 and vitiligo: Moreover, subgroup analysis revealed significant increase in FOXP3 expression after the treatment, in human studies (p = 0.003, 3.34 [1.13, 5.54]), Figure 5(b)) and vitiligo mice model studies (p = 0.0008, SMD: 3.43 [1.44, 5.43]), Figure 5(b)).